Global Dry Eye Syndrome Drugs Market Research Report 2024
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibiotic Drops
1.2.3 Hormone Drops
1.2.4 Artificial Tears
1.3 Market by Application
1.3.1 Global Dry Eye Syndrome Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dry Eye Syndrome Drugs Market Perspective (2019-2030)
2.2 Dry Eye Syndrome Drugs Growth Trends by Region
2.2.1 Global Dry Eye Syndrome Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dry Eye Syndrome Drugs Historic Market Size by Region (2019-2024)
2.2.3 Dry Eye Syndrome Drugs Forecasted Market Size by Region (2025-2030)
2.3 Dry Eye Syndrome Drugs Market Dynamics
2.3.1 Dry Eye Syndrome Drugs Industry Trends
2.3.2 Dry Eye Syndrome Drugs Market Drivers
2.3.3 Dry Eye Syndrome Drugs Market Challenges
2.3.4 Dry Eye Syndrome Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dry Eye Syndrome Drugs Players by Revenue
3.1.1 Global Top Dry Eye Syndrome Drugs Players by Revenue (2019-2024)
3.1.2 Global Dry Eye Syndrome Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Dry Eye Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dry Eye Syndrome Drugs Revenue
3.4 Global Dry Eye Syndrome Drugs Market Concentration Ratio
3.4.1 Global Dry Eye Syndrome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dry Eye Syndrome Drugs Revenue in 2023
3.5 Dry Eye Syndrome Drugs Key Players Head office and Area Served
3.6 Key Players Dry Eye Syndrome Drugs Product Solution and Service
3.7 Date of Enter into Dry Eye Syndrome Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dry Eye Syndrome Drugs Breakdown Data by Type
4.1 Global Dry Eye Syndrome Drugs Historic Market Size by Type (2019-2024)
4.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2025-2030)
5 Dry Eye Syndrome Drugs Breakdown Data by Application
5.1 Global Dry Eye Syndrome Drugs Historic Market Size by Application (2019-2024)
5.2 Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dry Eye Syndrome Drugs Market Size (2019-2030)
6.2 North America Dry Eye Syndrome Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dry Eye Syndrome Drugs Market Size by Country (2019-2024)
6.4 North America Dry Eye Syndrome Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dry Eye Syndrome Drugs Market Size (2019-2030)
7.2 Europe Dry Eye Syndrome Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dry Eye Syndrome Drugs Market Size by Country (2019-2024)
7.4 Europe Dry Eye Syndrome Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dry Eye Syndrome Drugs Market Size (2019-2030)
8.2 Asia-Pacific Dry Eye Syndrome Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dry Eye Syndrome Drugs Market Size (2019-2030)
9.2 Latin America Dry Eye Syndrome Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dry Eye Syndrome Drugs Market Size by Country (2019-2024)
9.4 Latin America Dry Eye Syndrome Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dry Eye Syndrome Drugs Market Size (2019-2030)
10.2 Middle East & Africa Dry Eye Syndrome Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Dry Eye Syndrome Drugs Introduction
11.1.4 Allergan Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.1.5 Allergan Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Dry Eye Syndrome Drugs Introduction
11.2.4 Novartis Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Santen
11.3.1 Santen Company Detail
11.3.2 Santen Business Overview
11.3.3 Santen Dry Eye Syndrome Drugs Introduction
11.3.4 Santen Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.3.5 Santen Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Dry Eye Syndrome Drugs Introduction
11.4.4 Takeda Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 Otsuka
11.5.1 Otsuka Company Detail
11.5.2 Otsuka Business Overview
11.5.3 Otsuka Dry Eye Syndrome Drugs Introduction
11.5.4 Otsuka Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.5.5 Otsuka Recent Development
11.6 Eyegate Pharma
11.6.1 Eyegate Pharma Company Detail
11.6.2 Eyegate Pharma Business Overview
11.6.3 Eyegate Pharma Dry Eye Syndrome Drugs Introduction
11.6.4 Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.6.5 Eyegate Pharma Recent Development
11.7 Can-Fite BioPharma
11.7.1 Can-Fite BioPharma Company Detail
11.7.2 Can-Fite BioPharma Business Overview
11.7.3 Can-Fite BioPharma Dry Eye Syndrome Drugs Introduction
11.7.4 Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.7.5 Can-Fite BioPharma Recent Development
11.8 Bausch and Lomb
11.8.1 Bausch and Lomb Company Detail
11.8.2 Bausch and Lomb Business Overview
11.8.3 Bausch and Lomb Dry Eye Syndrome Drugs Introduction
11.8.4 Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.8.5 Bausch and Lomb Recent Development
11.9 Auven Therapeutics (Celtic)
11.9.1 Auven Therapeutics (Celtic) Company Detail
11.9.2 Auven Therapeutics (Celtic) Business Overview
11.9.3 Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Introduction
11.9.4 Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.9.5 Auven Therapeutics (Celtic) Recent Development
11.10 Bridge Pharma
11.10.1 Bridge Pharma Company Detail
11.10.2 Bridge Pharma Business Overview
11.10.3 Bridge Pharma Dry Eye Syndrome Drugs Introduction
11.10.4 Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.10.5 Bridge Pharma Recent Development
11.11 Cellzome
11.11.1 Cellzome Company Detail
11.11.2 Cellzome Business Overview
11.11.3 Cellzome Dry Eye Syndrome Drugs Introduction
11.11.4 Cellzome Revenue in Dry Eye Syndrome Drugs Business (2019-2024)
11.11.5 Cellzome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Dry Eye Syndrome Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibiotic Drops
Table 3. Key Players of Hormone Drops
Table 4. Key Players of Artificial Tears
Table 5. Global Dry Eye Syndrome Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Dry Eye Syndrome Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Dry Eye Syndrome Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Dry Eye Syndrome Drugs Market Share by Region (2019-2024)
Table 9. Global Dry Eye Syndrome Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Dry Eye Syndrome Drugs Market Share by Region (2025-2030)
Table 11. Dry Eye Syndrome Drugs Market Trends
Table 12. Dry Eye Syndrome Drugs Market Drivers
Table 13. Dry Eye Syndrome Drugs Market Challenges
Table 14. Dry Eye Syndrome Drugs Market Restraints
Table 15. Global Dry Eye Syndrome Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Dry Eye Syndrome Drugs Market Share by Players (2019-2024)
Table 17. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome Drugs as of 2023)
Table 18. Ranking of Global Top Dry Eye Syndrome Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Dry Eye Syndrome Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dry Eye Syndrome Drugs Product Solution and Service
Table 22. Date of Enter into Dry Eye Syndrome Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dry Eye Syndrome Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Dry Eye Syndrome Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Dry Eye Syndrome Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Dry Eye Syndrome Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Dry Eye Syndrome Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Dry Eye Syndrome Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Dry Eye Syndrome Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Dry Eye Syndrome Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Dry Eye Syndrome Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Dry Eye Syndrome Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Dry Eye Syndrome Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Dry Eye Syndrome Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Dry Eye Syndrome Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Dry Eye Syndrome Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Dry Eye Syndrome Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Dry Eye Syndrome Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Allergan Company Detail
Table 48. Allergan Business Overview
Table 49. Allergan Dry Eye Syndrome Drugs Product
Table 50. Allergan Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 51. Allergan Recent Development
Table 52. Novartis Company Detail
Table 53. Novartis Business Overview
Table 54. Novartis Dry Eye Syndrome Drugs Product
Table 55. Novartis Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 56. Novartis Recent Development
Table 57. Santen Company Detail
Table 58. Santen Business Overview
Table 59. Santen Dry Eye Syndrome Drugs Product
Table 60. Santen Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 61. Santen Recent Development
Table 62. Takeda Company Detail
Table 63. Takeda Business Overview
Table 64. Takeda Dry Eye Syndrome Drugs Product
Table 65. Takeda Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 66. Takeda Recent Development
Table 67. Otsuka Company Detail
Table 68. Otsuka Business Overview
Table 69. Otsuka Dry Eye Syndrome Drugs Product
Table 70. Otsuka Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 71. Otsuka Recent Development
Table 72. Eyegate Pharma Company Detail
Table 73. Eyegate Pharma Business Overview
Table 74. Eyegate Pharma Dry Eye Syndrome Drugs Product
Table 75. Eyegate Pharma Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 76. Eyegate Pharma Recent Development
Table 77. Can-Fite BioPharma Company Detail
Table 78. Can-Fite BioPharma Business Overview
Table 79. Can-Fite BioPharma Dry Eye Syndrome Drugs Product
Table 80. Can-Fite BioPharma Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 81. Can-Fite BioPharma Recent Development
Table 82. Bausch and Lomb Company Detail
Table 83. Bausch and Lomb Business Overview
Table 84. Bausch and Lomb Dry Eye Syndrome Drugs Product
Table 85. Bausch and Lomb Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 86. Bausch and Lomb Recent Development
Table 87. Auven Therapeutics (Celtic) Company Detail
Table 88. Auven Therapeutics (Celtic) Business Overview
Table 89. Auven Therapeutics (Celtic) Dry Eye Syndrome Drugs Product
Table 90. Auven Therapeutics (Celtic) Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 91. Auven Therapeutics (Celtic) Recent Development
Table 92. Bridge Pharma Company Detail
Table 93. Bridge Pharma Business Overview
Table 94. Bridge Pharma Dry Eye Syndrome Drugs Product
Table 95. Bridge Pharma Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 96. Bridge Pharma Recent Development
Table 97. Cellzome Company Detail
Table 98. Cellzome Business Overview
Table 99. Cellzome Dry Eye Syndrome Drugs Product
Table 100. Cellzome Revenue in Dry Eye Syndrome Drugs Business (2019-2024) & (US$ Million)
Table 101. Cellzome Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Dry Eye Syndrome Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Dry Eye Syndrome Drugs Market Share by Type: 2023 VS 2030
Figure 3. Antibiotic Drops Features
Figure 4. Hormone Drops Features
Figure 5. Artificial Tears Features
Figure 6. Global Dry Eye Syndrome Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Dry Eye Syndrome Drugs Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Household Use Case Studies
Figure 11. Dry Eye Syndrome Drugs Report Years Considered
Figure 12. Global Dry Eye Syndrome Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Dry Eye Syndrome Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Dry Eye Syndrome Drugs Market Share by Region: 2023 VS 2030
Figure 15. Global Dry Eye Syndrome Drugs Market Share by Players in 2023
Figure 16. Global Top Dry Eye Syndrome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome Drugs as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Dry Eye Syndrome Drugs Revenue in 2023
Figure 18. North America Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Dry Eye Syndrome Drugs Market Share by Country (2019-2030)
Figure 20. United States Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Dry Eye Syndrome Drugs Market Share by Country (2019-2030)
Figure 24. Germany Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Dry Eye Syndrome Drugs Market Share by Region (2019-2030)
Figure 32. China Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Dry Eye Syndrome Drugs Market Share by Country (2019-2030)
Figure 40. Mexico Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Dry Eye Syndrome Drugs Market Share by Country (2019-2030)
Figure 44. Turkey Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Dry Eye Syndrome Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Allergan Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 48. Santen Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 49. Takeda Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 50. Otsuka Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 51. Eyegate Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 52. Can-Fite BioPharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 53. Bausch and Lomb Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 54. Auven Therapeutics (Celtic) Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 55. Bridge Pharma Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 56. Cellzome Revenue Growth Rate in Dry Eye Syndrome Drugs Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed